Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis

Gut

Volumn 38, Issue 6, 1996, Pages 841-845

  Zhang, Q B ^a,b   Nakshabendi, I M ^a   Mokhashi, M S ^a   Dawodu, J B ^a   Gemmell, C G ^a   Russell, R I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

cytotoxin; free oxygen radicals; Helicobacter pylori; peptic ulcer

Indexed keywords

CYTOTOXIN;

ADULT; AGED; ARTICLE; CHRONIC GASTRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PEPTIC ULCER; PRIORITY JOURNAL; RESPIRATORY BURST; TOXIN SYNTHESIS;

EID: 0030016162     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.6.841     Document Type: Article

References (23)

1. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants and human disease: where arc we now? J Lab Clin Med 1992; 119: 598-620.
2. Simmonds NJ, Rampton DS. Inflammatory bowel disease - a radical view. Gut 1993; 34: 865-8.
3. Phull PS, Green CJ, Jacyna MR. A radical view of the stomach: the role of oxygen-derived free radicals and antioxidants in gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 265-74.
4. Davies GR, Simmonds NJ, Stevens TRJ, Grandison A, Blake DR, Rampton DS. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992; 33: 1467-72.
5. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988; 33 (suppl): 6-15S.
6. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischaemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253: 699-703.
7. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
8. Davies GR, Simmonds NJ, Stevens TRJ, Sheaff MT, Banatvala N, Laurenson IF, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
9. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-9.
10. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470-5.
11. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225-6.
12. Crabtree JE, Figura N, Taylor JD, Bugnoli M, Armellini D, Tompkins DS. Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol 1992; 45: 733-4.
13. Mai UEH, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PA. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysacchride-independent mechanism. J Clin Invest 1991; 87: 894-900.
14. Evans DJ, Evans DG, Takemura T, Nakano H, Lampen HC, Graham DT, et al. Characterization of a Helicobacter pylon neutrophil-activating protein. Infect Immun 1995; 63: 2213-20.
15. Taha AS, Fraser WD, Kelly RW, Gemmell CG, Lee FD, Russell RI. Inhibition of human gastric cyclic AMP production by Helicobacter pylori protein - possible involvement of mucosal prostaglandin E2. Aliment Pharmacol Therap 1991; 5: 379-89.
16. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-12.
17. Mckinlay AW, Young A, Russell I, Gemmell CG. Opsonic requirements of Helicobacter pylori. J Med Microbiol 1993; 38: 209-15.
18. Das SS, Karim QN, Easmon CSF. Opsonophagocytosis of Campylobacter pylori. J Med Microbiol 1988; 27: 125-30.
19. Briheim G, Stendahl O, Dahlgren C. Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun 1984; 45: 1-5.
20. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tomplins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120KDa protein, peptic ulceration and gastric pathology. Lancer 1991; 338: 332-5.
21. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and the CagA is not necessary for the expression of the vacuolating toxin. Infect Immun 1995; 63: 94-8.
22. Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945-50.
23. Nielson H, Andersen LP. Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 1992; 103: 1747-53.